Skip to main content

Table 1 Baseline characteristics before and after matching cohorts

From: Association of menopausal status with COVID-19 outcomes: a propensity score matching analysis

Characteristics No. (%) before PSM No. (%) after PSM
  Total Men (N = 133) Women (N = 167) p value Total Men (N = 101) Women (N = 101) p value
Age (mean± SD), years 65.3 ± 14.6 65.6 ± 14.6 65.0 ± 14.7 0.74 65.3 ± 14.8 65.2 ± 14.9 65.4 ± 14.7 0.92
 Age ≥ 65 148 (49.3) 78 (58.6) 70 (41.9) 0.004* 83 (41.1) 41 (40.6) 42 (41.6) 0.89
 Age < 65 152 (50.7) 55 (41.4) 97 (58.1) 119 (58.9) 60 (59.4) 59 (58.4)
BMI
 Under and normal weight 220 (73.3) 93 (69.9) 127 (76.0) 0.47 146 (72.2) 71 (70.3) 75 (74.2) 0.3
 Overweight 69 (23.0) 35 (26.3) 34 (20.4) 49 (24.3) 28 (27.7) 21 (20.8)
 Obese 11 (3.7) 5 (3.8) 6 (3.6) 7 (3.5) 2 (2.0) 5 (5.0)
Comorbidities
 Hypertension 196 (65.3) 94 (70.7) 102 (61.1) 0.08 130 (64.4) 66 (65.3) 64 (63.4) 0.77
 Diabetes 57 (19.0) 26 (19.5) 31 (18.6) 0.83 37 (18.3) 21 (3.6) 16 (3.6) 0.36
 Cancer 8 (26.7) 5 (3.8) 3 (1.8) 0.29 3 (1.5) 2 (20.8) 1 (1.0) 0.56
 Coronary heart disease 57 (19.0) 24 (18.0) 33 (19.8) 0.71 39 (19.3) 18 (17.8) 21 (20.8) 0.59
 COPD 39 (13.0) 24 (61.5) 15 (38.5) 0.02* 22 (10.9) 12 (11.9) 10 (10.0) 0.65
 Cerebrovascular disease 30 (10.0) 14 (46.7) 16 (53.3) 0.79 25 (12.4) 11 (10.0) 14 (13.9) 0.52
Treated with corticosteroids
 Yes 19 (6.3) 13 (9.8) 6 (3.6) 0.03* 9 (4.5) 3 (3.0) 6 (5.9) 0.31
 No 281 (93.7) 120 (90.2) 161 (96.4) 193 (95.5) 98 (97.0) 95(94.1)
Treated with interferon
 Yes 35 (11.7) 16 (12.0) 19 (11.4) 0.86 176 (87.1) 88 (87.1) 88 (87.1) 1
 No 265 (88.3) 117 (88.0) 148 (88.6) 26 (12.9) 13 (12.9) 13 (12.9)
Treated with arbidol
 Yes 153 (51.0) 77 (57.9) 76 (45.5) 0.03* 101 (50.0) 49 (48.5) 52 (51.5) 0.67
 No 147 (49.0) 56 (42.1) 91 (54.5) 101 (50.0) 52 (51.5) 49 (48.5)
Lactic dehydrogenase
 Abnormal 38 (12.7) 20 (15.0) 18 (10.8) 0.27 180 (89.1) 91 (90.1) 89 (88.1) 0.65
 Normal 262 (87.3) 113 (85.0) 149 (89.2) 22 (10.9) 10 (9.9) 12 (11.9)
Lymphocyte
 Abnormal 207 (69.0) 81 (60.9) 126 (75.4) 0.007* 61 (30.2) 29 (28.7) 32 (31.7) 0.65
 Normal 93 (31.0) 52 (39.1) 41 (24.6) 141 (69.8) 72 (71.3) 69 (68.3)
C-reaction protein
 Abnormal 70 (23.3) 41 (30.8) 29 (17.4) 0.006* 161 (79.7) 80 (79.2) 81 (80.2) 0.86
 Normal 230 (76.7) 92 (69.2) 138 (82.6) 41 (20.3) 21 (20.8) 20 (19.8)
  1. Abbreviations: PSM propensity score matching, SD standard deviation, COPD chronic obstructive pulmonary disease
  2. *Significant at p < 0.05